A search of the miRBase (https://mirbase.org/) yielded reports on MAD2L1-mediated decreased susceptibility of ovarian cancer to PTX by miR-49325 (Fig. 1g). This evidence concerns the gene MAD2L1 and ovarian carcinoma.